Related Experiment Video
Updated: Jul 17, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Time to diagnosis in large vessel vasculitis: insights from a retrospective study at a tertiary rheumatology centre
Anna Kernder1, Pauline Bussmann2, Uta Kiltz2
1Ruhr University Bochum, Rheumazentrum Ruhrgebiet, Bochum, Germany Anna.Kernder@elisabethgruppe.de.
Insights
Diagnosing large vessel vasculitis (LVV) takes longer for Takayasu arteritis (TAK) than giant cell arteritis (GCA). Typical cranial symptoms shorten diagnosis time, while aortic involvement and prior rheumatology consultations prolong it.
Area of Science:
- Rheumatology
- Vascular Medicine
- Diagnostic Pathways
Background:
- Large vessel vasculitis (LVV) encompasses conditions like giant cell arteritis (GCA) and Takayasu arteritis (TAK).
- Timely diagnosis of LVV is critical to prevent irreversible organ damage and long-term complications.
- Diagnostic delays in LVV can stem from complex presentations and varied referral patterns.
Purpose of the Study:
- To analyze the diagnostic journey of patients with LVV.
- To identify factors contributing to the time to diagnosis in GCA and TAK.
- To assess the impact of referring medical specialties on diagnostic timelines.
Main Methods:
- Retrospective single-center study of 501 patients diagnosed with GCA or TAK (2014-2025).
- Data collection included clinical, laboratory, and referral information from medical records.
- Multivariate Cox regression and Kaplan-Meier curves analyzed factors influencing time to diagnosis.
Main Results:
- Median time to diagnosis was 89 days for GCA versus 245 days for TAK.
- Typical cranial symptoms correlated with shorter diagnostic intervals (HR 1.27, p=0.022).
- Aortic involvement prolonged diagnosis (HR 0.64, p<0.001), while ophthalmologist (HR 2.40, p=0.001) and cardiologist (HR 3.81, p=0.008) referrals expedited it. Prior rheumatology consultations were linked to delays (HR 0.73, p=0.004).
Conclusions:
- Diagnostic delay in LVV is influenced by disease subtype and clinical features.
- Takayasu arteritis diagnosis is significantly longer than GCA.
- Enhanced awareness and optimized referral pathways, particularly involving ophthalmology and cardiology, are essential to reduce diagnostic delays and improve patient outcomes.
Objective:
To evaluate the diagnostic pathway of patients affected by large vessel vasculitis (LVV) and to determine factors associated with the time to diagnosis including referring and previously consulted medical specialties.
Methods:
This retrospective single-centre study enrolled patients diagnosed with giant cell arteritis (GCA) and Takayasu arteritis (TAK) between January 2014 and May 2025. Clinical, laboratory and referral data were retrieved from medical records. Time to diagnosis was defined as the interval between the onset of first LVV-related symptoms and the confirmed diagnosis. Factors associated with diagnostic delay were analysed by multivariate Cox regression. Temporal differences were visualised using Kaplan-Meier curves.
Results:
In total, 501 patients were included (GCA n=488; TAK n=13). Compared with GCA (89 days (IQR 31-184)), the median time to diagnosis for TAK (245 days (IQR 31-1308)) was longer. Presentation with typical cranial symptoms was associated with a shorter diagnostic interval (HR 1.27, p=0.022), involvement of the aorta and its major branches was linked to prolonged delay (HR 0.64, p<0.001). Prior medical consultations by rheumatologists were associated with longer diagnostic delay (HR 0.73, p=0.004), whereas referrals by ophthalmologists (HR 2.40, p=0.001) and cardiologists (HR 3.81, p=0.008) were associated with earlier diagnosis.
Conclusion:
Diagnostic delay varies by subtype and clinical presentation. Time to diagnosis was longer in TAK compared with GCA, whereas typical cranial symptoms facilitate earlier diagnosis. Increasing awareness is crucial to minimise diagnostic delay and prevent organ damage.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies